VentureBeat July 30, 2021
Pharma cybersecurity, like other segments, faces new challenges as remote work takes over and proliferating security endpoints become more vulnerable. But as SARS-CoV-2 vaccine supply chain attacks show, the threats to pharma are particularly insidious.
Evidence shows pharma manufacturers’ cybersecurity systems aren’t keeping up with the increased workloads put on their supply chains, distribution networks, and development partners, a situation that puts valuable patient, supply chain, and pricing data at risk.
The pharma industry’s reliance on intellectual property and patents defining new vaccines, proprietary shipment data that exposes supply chain operations, and real-time patient data in the form of protected health information (PHI) makes the sector a prime target for all forms of cybercrime. PHI records are best sellers on...